Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rose-John

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Leukemia|December 22, 1999
Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitorsI Rappold, S M Watt, N Kusadasi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 1, 1996
Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiationM Ehlers, J Grötzinger, M Fischer, et al.
Cytokine|September 2, 1998
Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytesP Igaz, S Tóth, S Rose-John, et al.
Neuroscience Letters|April 18, 1998
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patientsP März, K Heese, C Hock, et al.
Annals of the New York Academy of Sciences|July 21, 1995
A region within the cytoplasmic domain of the interleukin-6 signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptorE Dittrich, C Gerhartz, S Rose-John, et al.
Cytokine|February 1, 1995
Soluble interleukin 6 receptor is biologically active in vivoA Mackiewicz, M Wiznerowicz, E Roeb, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 1998
In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6M Peters, G Blinn, F Solem, et al.
Cell Death & Disease|December 17, 2013
ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in miceP M Vidal, E Lemmens, A Avila, et al.
The American Journal of Pathology|November 14, 2000
Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic miceA G Brunello, J Weissenberger, A Kappeler, et al.
The Journal of Biological Chemistry|January 9, 1999
The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitroT Rakemann, M Niehof, S Kubicka, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Leukemia|December 22, 1999
Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitorsI Rappold, S M Watt, N Kusadasi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 1, 1996
Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiationM Ehlers, J Grötzinger, M Fischer, et al.
Cytokine|September 2, 1998
Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytesP Igaz, S Tóth, S Rose-John, et al.
Neuroscience Letters|April 18, 1998
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patientsP März, K Heese, C Hock, et al.
Annals of the New York Academy of Sciences|July 21, 1995
A region within the cytoplasmic domain of the interleukin-6 signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptorE Dittrich, C Gerhartz, S Rose-John, et al.
Cytokine|February 1, 1995
Soluble interleukin 6 receptor is biologically active in vivoA Mackiewicz, M Wiznerowicz, E Roeb, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 1998
In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6M Peters, G Blinn, F Solem, et al.
Cell Death & Disease|December 17, 2013
ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in miceP M Vidal, E Lemmens, A Avila, et al.
The American Journal of Pathology|November 14, 2000
Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic miceA G Brunello, J Weissenberger, A Kappeler, et al.
The Journal of Biological Chemistry|January 9, 1999
The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitroT Rakemann, M Niehof, S Kubicka, et al.
Pageof 17